These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 8101361)
1. MK-801 and phencyclidine act at phencyclidine sites that are not linked to N-methyl-D-aspartate activity to inhibit behavioral sensitization to kainate. Sun X; Larson AA Neuroscience; 1993 Jun; 54(3):773-9. PubMed ID: 8101361 [TBL] [Abstract][Full Text] [Related]
2. Regulation of sigma activity by the amino-terminus of substance P in the mouse spinal cord: involvement of phencyclidine (PCP) sites not linked to N-methyl-D-aspartate (NMDA) activity. Larson AA; Sun X Neuropharmacology; 1993 Sep; 32(9):909-17. PubMed ID: 7694172 [TBL] [Abstract][Full Text] [Related]
3. MK-801 inhibits the effects of capsaicin in the adult mouse by an action involving phencyclidine (PCP) sites not linked to NMDA activity. Sun X; Larson AA Neuroreport; 1993 Sep; 4(10):1147-50. PubMed ID: 7693010 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the role of spinal N-methyl-D-aspartate receptors in thermal nociception in the rat. Kolhekar R; Meller ST; Gebhart GF Neuroscience; 1993 Nov; 57(2):385-95. PubMed ID: 7906873 [TBL] [Abstract][Full Text] [Related]
6. L-homocysteate stimulates [3H]MK-801 binding to the phencyclidine recognition site and is thus an agonist for the N-methyl-D-aspartate-operated cation channel. Schwarz S; Zhou GZ; Katki AG; Rodbard D Neuroscience; 1990; 37(1):193-200. PubMed ID: 1700841 [TBL] [Abstract][Full Text] [Related]
7. In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception. DeLander GE; Wahl JJ Eur J Pharmacol; 1989 Jan; 159(2):149-56. PubMed ID: 2468511 [TBL] [Abstract][Full Text] [Related]
8. Behavioural and electoencephalographic interactions between haloperidol and PCP/sigma ligands in the rat. Sagratella S; Scotti de Carolis A; Pèzzola A; Popoli P Psychopharmacology (Berl); 1991; 105(4):485-91. PubMed ID: 1685250 [TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy. Massieu L; Thedinga KH; McVey M; Fagg GE Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181 [TBL] [Abstract][Full Text] [Related]
10. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors. Löscher W; Hönack D J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288 [TBL] [Abstract][Full Text] [Related]
11. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism. Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399 [TBL] [Abstract][Full Text] [Related]
12. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. Aanonsen LM; Wilcox GL J Pharmacol Exp Ther; 1987 Oct; 243(1):9-19. PubMed ID: 2822907 [TBL] [Abstract][Full Text] [Related]
13. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice. Irifune M; Shimizu T; Nomoto M; Fukuda T Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342 [TBL] [Abstract][Full Text] [Related]
14. Antinociception induced by 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1- phosphonic acid (CPP), an N-methyl-D-aspartate (NMDA) competitive antagonist, plus 6,7-dinitroquinoxaline-2,3-dione (DNQX), a non-NMDA antagonist, differs from that induced by MK-801 plus DNQX. Goettl VM; Larson AA Brain Res; 1994 Apr; 642(1-2):334-8. PubMed ID: 8032897 [TBL] [Abstract][Full Text] [Related]
15. Increased N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine does not mediate opioid withdrawal. Kreeger JS; Yukhananov RYu ; Larson AA Brain Res; 1994 Nov; 663(1):101-6. PubMed ID: 7850459 [TBL] [Abstract][Full Text] [Related]
16. Distinct neuroprotective profiles for sigma ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Lockhart BP; Soulard P; Benicourt C; Privat A; Junien JL Brain Res; 1995 Mar; 675(1-2):110-20. PubMed ID: 7796119 [TBL] [Abstract][Full Text] [Related]
17. The role of neurokinin and N-methyl-D-aspartate receptors in synaptic transmission from capsaicin-sensitive primary afferents in the rat spinal cord in vitro. Nagy I; Maggi CA; Dray A; Woolf CJ; Urban L Neuroscience; 1993 Feb; 52(4):1029-37. PubMed ID: 7680798 [TBL] [Abstract][Full Text] [Related]
18. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253 [TBL] [Abstract][Full Text] [Related]
19. Intrathecally administered D-cycloserine produces nociceptive behavior through the activation of N-methyl-D-aspartate receptor ion-channel complex acting on the glycine recognition site. Tan-No K; Esashi A; Nakagawasai O; Niijima F; Furuta S; Sato T; Satoh S; Yasuhara H; Tadano T J Pharmacol Sci; 2007 May; 104(1):39-45. PubMed ID: 17452810 [TBL] [Abstract][Full Text] [Related]
20. N-methyl-D-aspartate, kainate and quisqualate release endogenous adenosine from rat cortical slices. Hoehn K; White TD Neuroscience; 1990; 39(2):441-50. PubMed ID: 1982346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]